Supported by

Stents, scaffolds and DCB

Find all the latest content on stents and scaffolds published on this website.

Since 1986, when the first cardiovascular stent was implanted, the development of drug-eluting stents (DES) and the recent introduction of bioresorbable scaffolds have revolutionised interventional cardiology. Keep up-to-date with the latest research; evolving tools, devices and techniques; the role of adjunctive pharmacotherapy; advances in imaging techniques as well as the use of invasive imaging and functional assessment. Find out more…

Filtered By
Stents, scaffolds and DCB

543 results

Effect of 1-month dual antiplatelet therapy followed by clopidogrel vs 12-month dual antiplatelet therapy on cardiovascular and bleeding events in patients receiving PCI

09 Jul 2019

Results of the STOPDAPT-2 randomized clinical trial

Daniele Giacoppo

Reviewer

Daniele Giacoppo
Effect of 1-month DAPT followed by clopidogrel vs 12-month DAPT on cardiovascular and bleeding events in patients receiving PCI

The future of drug-coated balloon technology

What are the advantages and disadvantages of using drug-coated balloons (DCBs)? What are the most important indications for these devices? Join Alexandre Abizaid, Martin B. Leon and Antonio Colombo as they discuss the latest thinking on DCB technology. Discover the benefits of using sirolimus over paclitaxel...

DCB technology

Which interventional strategy is best for diabetic patients?

Which is the best revascularisation procedure to use in diabetic patients? Join Marco Valgimigli, Rafael Romaguera and Rosli Mohd Ali as they discuss the challenges of performing percutaneous coronary intervention (PCI) in everyday clinical practice in these patients. The integration of functional assessment of intermediate lesions, intravascular...

Which interventional strategy is best for diabetic patients?

Left main and complex bifurcation stenting via transradial approaches

04 Jul 2019 – From AICT-AsiaPCR 2019

Consult this session to learn more about the best treatment options for patients presenting with left main and complex bifurcations lesions, and gain insights on vascular healing and latest clinical outcomes with Ultimaster DES.

Left main and complex bifurcation stenting via transradial approaches

Extended DAPT: who & how can PEGASUS be applied in clinical practice?

04 Jul 2019 – From AICT-AsiaPCR 2019

Consult this session to learn more about PEGASUS, a trial designed to evaluate the potential benefit of DAPT beyond 1 year after a myocardial infarction, with or without stent implantation: to whom & how can extended DAPT be applied in clinical practice? Discover it now!

Extended DAPT: who & how can PEGASUS be applied in clinical practice?

Superior patient outcomes with bioresorbable technologies

04 Jul 2019 – From AICT-AsiaPCR 2019

Consult this session to discover a selection of studies demonstrating superior patient outcomes with bioresorbable technologies, and discover which DES you should use and how ultrathin strut DES differs from the others.

Superior patient outcomes with bioresorbable technologies

Challenging cases

04 Jul 2019 – From AICT-AsiaPCR 2019

Consult this session to discover challenging cases and their management: cardioembolic AMI in a post-MVR patient, anomalous left coronary artery origin from pulmonary artery in an asymptomatic adult, PCI in a patient with platelet function disorder, and more!

Challenging cases

Do ultrathin stents improve outcomes?

Do newer generation drug-eluting stents with ultrathin struts improve clinical outcomes for patients undergoing percutaneous coronary intervention (PCI)? Join Ashwin Mehta, Upendra Kaul and Anirban Choudhary in a discussion about the TALENT non-inferiority trial, which compared PCI using the Supraflex sirolimus-eluting stent with ultrathin struts with...

Ultrathin stent outcomes

Hope for improved PCI outcomes in diabetic patients with the Abluminus stent

Although huge progress has been made over the last four decades in percutaneous coronary intervention, the results in diabetic patients are still suboptimal, with higher rates of restenosis, target lesion revascularisation, vessel failures and mortality. Luca Testa, Roxana Mehran and Ashok Seth discuss the problems that...

Hope for improved PCI outcomes in diabetic patients with the Abluminus stent

Sirolimus-eluting DCB: update from the Eastbourne study

In this short video, Bernado Cortese (Italy) describes the interim analysis of the Eastbourne study, which is evaluating the performance of a sirolimus-eluting DCB for the treatment of any type of coronary lesion, including native vessel disease and in-stent restenosis. The Eastbourne registry is enrolling patients...